Full results of lecanemab Phase 3 confirmatory Clarity AD study for early Alzheimer's disease published in the New England Journal of Medicine
/PRNewswire/ -- BioArctic AB's (publ) (Nasdaq: BIOA B) (Stockholm: BIOA B) partner Eisai announced today that the results from the large global Phase 3...